Susceptibility of malignant plasma cells to HA-1H specific lysis suggests a role for the minor histocompatibility antigen HA-1 in the graft-versus-myeloma effect

This publication has 11 references indexed in Scilit:

• The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma
  Blood, 2004
• Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma
  Blood, 2003
• Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells
  Clinical Immunology, 2003
• Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
  Proceedings of the National Academy of Sciences, 2003
• Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein
  Leukemia, 2003
• Induction of HA‐1‐specific cytotoxic T‐cell clones parallels the therapeutic effect of donor lymphocyte infusion
  British Journal of Haematology, 2002
• Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies
  Seminars in Hematology, 2002
• Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome
  Current Opinion in Immunology, 2001
• A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia
  The Journal of Experimental Medicine, 1999
• Genomic identification of the minor histocompatibility antigen HA‐1 locus by allele‐specific PCR
  Tissue Antigens, 1998